Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Apolipoprotein A1 As a Novel Anti-Implantation Biomarker in Polycystic Ovary Syndrome: A Case-Control Study Publisher



Amjadi F1 ; Aflatoonian R2 ; Javanmard SH3 ; Saifi B4 ; Ashrafi M5 ; Mehdizadeh M6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Departments of Anatomy, School of Medicine, Iran University of Medical Science, Tehran, Iran
  2. 2. Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, The Academic Center for Education Culture and Research (ACECR), Tehran, Iran
  3. 3. Department of Physiology, Applied Physiology Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Anatomy, Mashhad Medical Branch, Islamic Azad University, Mashhad, Iran
  5. 5. Departments of Obstetrics and Gynecology, School of Medicine, Iran University of Medical Science, Tehran, Iran
  6. 6. Cellular and Molecular Research Center, Department of Anatomical Sciences, Iran University of Medical Sciences, Tehran, Iran

Source: Journal of Research in Medical Sciences Published:2015


Abstract

Background: Women with polycystic ovary syndrome have lower pregnancy rates, possibly due to the decreased uterine receptivity. Successful implantation depends on protein networks that are essential for cross-talk between the embryo and endometrium. Apolipoprotein A1 has been proposed as a putative anti-implantation factor. In this study, we evaluated apolipoprotein A1 expression in human endometrial tissues. Materials and Methods: Endometrial apolipoprotein A1 messenger RNA (mRNA) and protein expression were investigated using quantitative real-time polymerase chain reaction (PCR) and Western blot. The distribution of apolipoprotein A1 was also detected by immunostaining. Samples were obtained from 10 patients with polycystic ovary syndrome and 15 healthy fertile women in the proliferative (on day 2 or day 3 before ovulation, n = 7) and secretory (on days 3-5 after ovulation, n = 8) phases. Results: Endometrial apolipoprotein A1 expression was upregulated in patients with polycystic ovary syndrome compared to normal subjects. However, apolipoprotein A1 expression in the proliferative phase was significantly higher than in the luteal phase (P value < 0.05). Conclusion: It seems that differentially expressed apolipoprotein A1 negatively affects endometrial receptivity in patients with polycystic ovary syndrome. The results showed that apolipoprotein A1 level significantly changes in the human endometrium during the menstrual cycle with minimum expression in the secretory phase, coincident with the receptive phase (window of implantation). Further studies are required to clarify the clinical application of this protein. © 2015 Journal of Research in Medical Sciences.
Experts (# of related papers)
Other Related Docs
9. Implantation Window and Angiogenesis, Journal of Cellular Biochemistry (2017)
12. Micrornas in Female Infertility: An Overview, Cell Biochemistry and Function (2021)
19. Factors Associated With In-Vitro Fertilization Success in Polycystic Ovary Syndrome, Journal of Obstetrics, Gynecology and Cancer Research (2024)